Five faculty members from the University of Pennsylvania have been named fellows of the American Association for the Advancement of Science.
Health & Medicine
Media Contact:Karen Kreeger | email@example.com | 215-349-5658 November 25, 2013
Drugs that inhibit the activity of enzymes called histone deacetylases (HDACs) are being widely developed for treating cancer and other diseases, with two already on the market. Researchers at the Perelman School of Medicine, University of Pennsylvania, show that a major HDAC still functions in mice even when its enzyme activity is abolished, suggesting that the beneficial effects of HDAC inhibitors may not actually be through inhibiting HDAC activity, and thus warranting the reassessment of the molecular targets of this class of drugs.
Douglas Smith of the Perelman School of Medicine talks about leading a team of researchers who have developed a blood test to identify when concussions will lead to long-term problems.
New research presented today at the 2013 Scientific Sessions of the American Heart Association by researchers at the Perelman School of Medicine at the University of Pennsylvania found no difference in outcomes at one-year between two recommended surgical options for treating ischemic mitral regurgitation (IMR) – repair of the leaky valve or its rep
The instructions for building all of the body’s proteins are contained in a person’s DNA, a string of chemicals that, if unwound and strung end to end, would form a sentence 3 billion letters long.